Navigation Links
Founder in Medical Technology

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... of the Entertainment Industry Foundation's Board of Directors and founder of the Sherry Lansing Foundation; EIF President and CEO Lisa Paulsen; Katie Couric; Noreen Fraser, founder of the Noreen Fraser Foundation (NFF) and a cancer survivor; EIF Vice ...

Stem Cell Pioneer to Speak to A.L.L. Personhood Conference

... ) Dr. Theresa Deisher, founder and CEO of AVM Biotechnology and President of Sound Choice Pharmaceutical ... movement including keynote speaker Judie Brown; Ambassador Alan Keyes, founder and chairman of the Declaration Foundation; 40 Days for Life leader David ...

Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa

... benefit in reducing cardiovascular disease factors," said Mark Blumenthal, founder and executive director of the American Botanical Council, the leading ... clinical trials. J Nutr. 2003;133(10):3285S-3292S. Editor's Note: ABC founder & Executive Director Mark Blumenthal is available for interviews. Please ...

(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa

... Led by Don MacKinnon, founder of HEAR Music NEW YORK, June 30 /PRNewswire/ -- In the fall of 2008, ... medicine for those living with AIDS in Africa. Don MacKinnon, founder of HEAR Music and former Vice President of Music & Entertainment of ...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

... globally and we are determined to improve the quality of patient's lives by developing a new therapy," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group." "This alliance with Debiopharm represents important validation of Mercury's technology and of the growing appreciation ...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

... that is highly precise, and this approach would offer women the added benefit of being both non-invasive and cost-effective," stated Eduardo Cruz, founder & CEO of Cryopraxis Cryobiology Ltd. "Additionally, this new method would potentially allow for earlier diagnosis of the disease, and ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... pleased that Swissmedic has recognised the potential of treatment of sexual deviations with Moapar(R)," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group. "This is an important signal for us, as we move closer to providing an alternative treatment for this controversial disorder. ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... pleased that Swissmedic has recognised the potential of treatment of sexual deviations with Moapar(R)," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group. "This is an important signal for us, as we move closer to providing an alternative treatment for this controversial disorder. ...

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

... take advantage of the substance "prostone" in the development of Rescula(R) eyedrop 0.12%. Prostone was discovered in 1980's by Dr. Ryuji Ueno, the founder of the company. Rescula(R) eyedrop 0.12% that causes less topical and systemic adverse reactions demonstrates steady ocular pressure-decreasing ...

McCaughey Urges Use of First NYS Hospital Infection Report

... infection, but should consider the average infection rate for each hospital and give preference to the lowest one. Betsy McCaughey is founder and Chairman of the Committee to Reduce Infection Deaths, and a former Lt. Governor of New York State . ...

New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%

... is used in most prebiotic supplements and enhanced foods. "The implications of this study are somewhat staggering," says Jackson GI Chairman and founder Frank W. Jackson, M.D. "While the research doesn't quite yet justify a claim that Prebiotin lengthens human life, the study is nevertheless ...

ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases

... for inflammatory diseases may be pursed through clinical trials focused on arachidonic acid specific surrogate end points. David K. Barker, founder and CEO of ALP Life Sciences, LLC stated, "The preliminary evidence for the Nanoveson(TM) hypotheses is very promising, however, it should be ...

Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries

... fourth product we have developed and made available to doctors for the treatment of a serious condition," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group. "We can now offer people suffering from this controversial disorder an alternative and a complementary treatment to surgical ...

Scottsdale Facility to Be First in U.S. to Showcase True REST Technology

... and commercial real estate industry. He also was an assistant manager of a retail store, giving him a rounded experience that led to his new role of founder of True REST. Contact: Nick Janicki 3939 S Illinois St Chandler, AZ 85248 nick@true-rest.com 602-481-3814 Fax: ...

Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech

... It recognizes the remarkable achievements and dedication of the entire Sanaria team and our collaborators," states Stephen L. Hoffman, Sanaria's founder and CEO. Sanaria's candidate malaria vaccine is composed of live, attenuated parasites. This unique formulation, having satisfied rigorous FDA ...

New Research Shows Antidepressants May Thwart Breast Cancer Treatment

... "With more than 100,000 women potentially affected, these data represent a significant health finding," asserts Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist at Lankenau Hospital in the Philadelphia area. Preliminary, limited information from another study ...

Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support

... and peripheral blood. FT1050 was discovered by Leonard Zon, M.D., director of the Stem Cell Program at Children's Hospital Boston and a scientific founder of Fate Therapeutics and is part of an exclusive license granted to Fate by Children's Hospital Boston and Massachusetts General Hospital. ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... "The dual differentiation of these properties may provide advance warning of the future course of H1N1," noted Samuel Bogoch MD PhD, chairman and founder of Replikins Ltd. "Our understanding of the protein chemistry of rapid replication enables us to develop synthetic vaccines specifically tailored to ...

Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine

... human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that Chuck Panozzo, founder of the internationally acclaimed rock band Styx, has joined the GeoVax Labs awareness campaign as an advocate of the Company's promising HIV/AIDS ...

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

... that grow on marginal land or in more arid climates and that do not compete with agriculture for food production," said J. Craig Venter, Ph.D., founder and CEO of SGI. "SGI and ACGT will be hard at work on the next steps to use our methods to improve these oilseed crops so that we have higher ...

Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)

... TMJ programs and courses for members of the dental and medical professions, as well as for the general public, for more than two decades. He is the founder and Director of THE FELDENKRAIS MOVEMENT INSTITUTE, the world's most experienced training organization for the Feldenkrais Method(R). Dr. Wildman is ...

BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting

... tumor post treatment. OncoVEX GM-CSF was detected in injected and adjacent uninjected tumors at a therapeutic dose. Dr Robert Coffin, founder and Chief Technology Officer, for BioVex, said: "Loco-regional control is extremely important in head and neck cancer where loco regional ...

Tris Pharma Announces Acceptance of Its First Two NDAs

... "FDA's acceptance of our two NDAs validates Tris' OralXR platform, and is an important milestone for the company," says Tris Pharma CEO and founder Ketan Mehta. "We have an exciting future, with a robust pipeline of more than 20 extended release products in different therapeutic categories ...

ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award

... application is recognized as the most innovative clinical trial management solution by such a distinguished panel of judges," stated Lance Converse, founder and CEO of ePharmaSolutions. "We have worked exceptionally hard to develop solutions that help solve some of the industries biggest causes of study ...

Clinical Update - Debio 025 in Hepatitis C

... regimen, are very important to us, as they confirm that Debio 025 is a potent anti-HCV agent," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group. "We are making it our mission to find a cure for this widely spread and life threatening disease and these findings bring us one ...

MedNet Solutions Certified to Score SF-12v2 Health Survey

... Assessments. Our Outcomes Insight Consulting(TM) Division can develop customized PROs and provide in-depth analysis of the results. QualityMetric's founder and Chief Science Officer, John E. Ware, Jr., PhD is a thought-leader in the field of psychometrics and health outcome measurement. Visit us at ....

Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments

... With this investment from Foundation Venture Capital Group we look toward moving our research further at a more rapid pace." Dr. Kachlany, founder of Actinobac Biomed and an associate professor of oral biology, microbiology and molecular genetics at UMDNJ-New Jersey Dental School, discovered the ...

Leader in Prostate Health Urges Prostate Cancer Screening in Face of Contradicting Data

... of the PLCO study and head of the Urologic Oncology Department at the University of Colorado Health Sciences Center . Dr. Crawford is also the founder and chairman of the PCEC. "Since the Prostate-Specific Antigen test was made available, we have seen a decrease in deaths attributed to ...

Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year

... energy cyclotron. The cyclotron built around this magnet will be the most compact source for proton therapy available today." said Dr. Kenneth Gall, founder and Chief Technology Officer. "All of the Monarch250 sub-systems are now in the final phases of manufacturing and will be ready to ship to our first ...

IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile

... patient had complete mobility and almost the same strength with a minimal scar. He was working and leading a normal life." Said Bob Rabiner, founder and CEO of IlluminOss Medical, "We are pleased to work with Dr. von Unger and the team at Hospital del Trabajadar. This case represents a major ...

Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis

... a lethal and ultimately fatal disease, these data indicate that Pirfenidone may allow them breathe better, walk further, and live longer," said CPF founder and Chief Operating Officer Mark Shreve. "If approved, Pirfenidone would represent a historic and desperately needed advance in the treatment of PF." ...

Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis

... of the drug that you could never achieve with an oral systemic drug because it would cause systemic toxicity," said James R. Baker, Jr., M.D., founder and chairman of NanoBio Corp. "We can nebulize our nanoemulsion so that it is deposited directly into the lungs to kill these highly resistant ...

Cardiac Disease in Women Remains Untreated for Decades

... and a Board of Director governing the day-to-day operations and growth. The HCMA is supported by grants and donations. Lisa Salberg, CEO and founder of the HCMA. For more information about the Hypertrophic Cardiomyopathy Association log on to www.4HCM.org . To schedule an interview with Lisa ...

Clinical Update - Debio 025 in Hepatitis C

... the risk of treatment failure for HCV patients and maximise their chances of sustained viral response," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group. "With over 170 million people infected with HCV worldwide, there is a real medical need for a treatment which we hope to ...

UK Must Maintain its Momentum in Stem Cell Expertise

... to deliver pioneering stem cell treatments if it is to remain at the forefront of medical technology. Professor Sir Christopher Evans, founder and chairman of Excalibur, welcomed the announcement that ReNeuron plc has received approval from the UK Medicines and Healthcare Products Regulatory ...

2008 Human Research Protection Award Recipients Announced

... -- The winner of the 2008 Award for Excellence in Human Research Protection was announced today by Dr. Peter G. Goldschmidt, President and founder of the Health Improvement Institute. The winner of the annual award was the University of Texas M.D. Anderson Cancer Center -- for its ...

New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement

... A nonprofit organization, Breastcancer.org serves more than 8 million visitors each year. Dr. Marisa C. Weiss is the President and founder of Breastcancer.org. She currently practices at Lankenau Hospital in the Philadelphia area, where she serves as the Director of Breast Radiation ...

Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings

... I believe swift development is warranted so we can provide women with an alternative to hormone therapy," said Wulf Utian, M.D., Ph.D., D.Sc. founder and President Emeritus of the North American Menopause Society and Menerba's Principal Clinical Investigator. The Company expects to ...

IBT Laboratories Expands its Menu of Tests for Immune Deficiency

... Pathway Function Test , at the November 2008 meeting of the American College of Allergy Asthma and Immunology in Seattle. According to IBT founder and Chief Executive Officer, John F. Halsey, Ph.D., these two tests provide physicians with much greater insight into a patient's immunology profile ...

J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory

... Marilyn & James Simons and Sherry Lansing at Gala New York City Event ROCKVILLE, Md., Nov. 12 /PRNewswire-USNewswire/ -- J. Craig Venter, Ph.D., founder and President of the J. Craig Venter Institute (JCVI), was awarded the Double Helix Medal from Cold Spring Harbor Laboratory (CSHL) on November 6th ...
Other Contents
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/24/2014)... As 2014 draws to a close, ... investing time and money into a new or tankless ... specializes in tankless and eco-friendly products or service. Greenstar ... heater in 2015 to research “green” and environmentally friendly ... Home Services specializes in eco-friendly and environmentally conscious ...
(Date:12/24/2014)... York (PRWEB) December 24, 2014 In ... the United States rode bicycles, hand cycles and recumbent ... D.C. in the inaugural CanAm Veterans’ Challenge . ... non-profit World T.E.A.M. Sports about this inspiring ride, is ... more than 50 full color photographs taken during the ...
(Date:12/24/2014)... 23, 2014 (HealthDay News) -- Each year, more than ... the United States occur because of extreme heat conditions, ... study finds that heat stroke is the leading cause ... as kidney failure and urinary tract infections, also put ... soar. The new data should help health care ...
(Date:12/24/2014)... -- Though most patients with obsessive-compulsive disorder (OCD) can ... percent to 20 percent have a form of the ... However, patients with this so-called "refractory OCD" do ... brain surgery that disables certain brain networks believed to ... patients most likely to benefit from the surgery, known ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 B. E. ... to healthcare providers, has been retained to lead a ... Tri-City Medical Center in Oceanside, Calif. The top ... B. E. Smith has recently placed more than 900 ... is a community owned, 397-bed, Gold Seal-approved, full-service acute-care ...
Breaking Medicine News(10 mins):Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 3Health News:Heat Stroke, Kidney Failure Help Drive Illnesses From Extreme Heat 2Health News:Scans May Spot People Who'll Benefit From Surgery for OCD 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 3
Other TagsOther Tags